Medco Promotes Wyeth’s Alavert As Part Of “Generics First” Program
This article was originally published in The Tan Sheet
Executive Summary
Wyeth's Alavert antihistamine allergy drug is featured in pharmacy benefits manager Medco Health Solutions' Generics First program
You may also be interested in...
Allegra Sales Decline Will Not Prompt OTC Switch, Aventis Says
Decreasing Allegra sales in the face of increased competition from OTC antihistamines will not lead Aventis to pursue a switch for the drug, the firm stated during an Oct. 30 call on third-quarter results
Allegra Sales Decline Will Not Prompt OTC Switch, Aventis Says
Decreasing Allegra sales in the face of increased competition from OTC antihistamines will not lead Aventis to pursue a switch for the drug, the firm stated during an Oct. 30 call on third-quarter results
Allegra Sales Decline Will Not Prompt OTC Switch, Aventis Says
Decreasing Allegra sales in the face of increased competition from OTC antihistamines will not lead Aventis to pursue a switch for the drug, the firm stated during an Oct. 30 call on third-quarter results